tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Ryan Halsted, 13 are a BUY (61.9%), 8 are a HOLD (38.1%).
Analyst Ryan Halsted, currently employed at RBC, carries an average stock price target met ratio of 55.56% that have a potential upside of 8.27% achieved within 31 days.
Ryan Halsted’s has documented 42 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on IQV, IQVIA Holdings at 29-Sep-2026.
Analyst best performing recommendations are on CRL (CHARLES RIVER LABORATORIES).
The best stock recommendation documented was for CRL (CHARLES RIVER LABORATORIES) at 8/6/2026. The price target of $282 was fulfilled within 5 days with a profit of $16.49 (6.21%) receiving and performance score of 12.42.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-May-2020
$380
$36.73 (10.70%)
$280
Buy Since 02-Apr-2017
$400
$56.73 (16.53%)
$430
6 days ago
(15-Oct-2026)
16/22 (72.73%)
$59.08 (17.33%)
566
Buy Since 29-Dec-2022
$388
$44.73 (13.03%)
$410
15 days ago
(06-Oct-2026)
12/14 (85.71%)
$70.75 (22.30%)
342
Hold Since 18-Aug-2026
$330
$-13.27 (-3.87%)
$330
1 months 14 days ago
(07-Sep-2026)
2/2 (100%)
$5.31 (1.64%)
24
Buy Since 12-Aug-2025
$395
$51.73 (15.07%)
$331
2 months 11 days ago
(10-Aug-2026)
5/8 (62.5%)
$61.78 (18.54%)
105
Which stock is Ryan Halsted most bullish on?
Which stock is Ryan Halsted most reserved on?
What Year was the first public recommendation made by Ryan Halsted?
